|

BBO-8520 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)1

Indications

  • Advanced Lung Carcinoma1
  • KRAS G12C1
  • Metastatic Non-Small Cell Lung Cancer1
  • Metastatic Lung Cancer1
  • NSCLC1

Birmingham, Alabama1 trial

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

O'Neal Comprehensive Cancer Center at UAB

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.